Talent Acquisition Associate (Contract) jobs in United States
cer-icon
Apply on Employer Site
company-logo

BridgeBio · 2 days ago

Talent Acquisition Associate (Contract)

BridgeBio is a pioneering company in biotech focused on developing life-changing medicines for patients with unmet needs. The Talent Acquisition Associate role is designed to enhance the candidate journey by leveraging automation and insights to improve hiring processes and provide exceptional experiences for candidates and interview teams.

BiotechnologyHealth CareLife ScienceMedicalPharmaceutical
check
Growth Opportunities

Responsibilities

Leverage automated scheduling functionalities within Greenhouse
Utilize data and insights, such as candidate survey and interviewing metrics, to inform process improvements
Deliver exceptional candidate and hiring manager experiences
Partner with Talent Acquisition Partners to ensure interview preparation materials and interview best practices are available and accessibility
Continuously evaluate and pilot emerging technologies to enhance efficiency and innovation in candidate experience
Support TA-related and cross-functional special projects and initiatives

Qualification

Talent AcquisitionAI-based scheduling toolsData analyticsCross-functional collaborationCuriosityCommunication skills

Required

2+ years in Talent Acquisition —ideally within high growth life sciences or technology industry
Demonstrated success partnering cross functionally with exceptional communication and credibility at all levels
Expertise in AI-based scheduling tools and ATS with learning agility and curiosity for applying AI or automation tools to elevate candidate experience
Advanced data intuition with proven skills in reporting, dashboards, talent analytics, and influencing business insights

Benefits

Annual performance bonus
Company equity
Generous health benefits

Company

BridgeBio

twittertwittertwitter
company-logo
BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.

Funding

Current Stage
Public Company
Total Funding
$4.9B
Key Investors
Blue OwlQatar Investment AuthorityKohlberg Kravis Roberts
2026-01-16Debt Financing· $550M
2025-02-25Post Ipo Debt· $500M
2024-03-04Post Ipo Equity· $250M

Leadership Team

leader-logo
Justin To
CEO, Skeletal Dysplasias (QED Therapeutics)
linkedin
leader-logo
Neil Kumar
CEO and Founder
linkedin
Company data provided by crunchbase